肝炎、肝がんを中心とした病態解明と新規診断・治療法の開発

1. Yoshikawa S, Yoshio S, Yoshida Y, Tsutsui Y, Kawai H, Yamazoe T, Mori T, Osawa Y, Sugiyama M, Iwamoto M, Watashi K, Kawaguchi T, Akita T, Tanaka J, Kikuchi Y, Mizokami M, Oka S, Kanto T, Gatanaga H.
   Impact of Immune Reconstitution-induced Hepatic Flare on HBsAg Loss in HBV/HIV-1-Coinfected Patients. J Infect Dis. 2020 Oct 19:jiaa662. doi: 10.1093/infdis/jiaa662.
   
   
   
2. Yamazoe T, Mori T, Yoshio S, Kanto T
   Hepatocyte ploidy and pathological mutations in hepatocellular carcinoma: impact on oncogenesis and therapeutics Global Health & Medicine. 2020; 2(5):273-281. doi: 10.35772/ghm.2020.01089
   

共著論文

1. Fukushima K, Satoh T, Sugihara F, Sato Y, Okamoto T, Mitsui Y, Yoshio S, Li S, Nojima S, Motooka D, Nakamura S, Kida H, Standley DM, Morii E, Kanto T, Yanagita M, Matsuura Y, Nagasawa T, Kumanogoh A, Akira S.
   Dysregulated Expression of the Nuclear Exosome Targeting Complex Component Rbm7 in Nonhematopoietic Cells Licenses the Development of Fibrosis. Immunity. 2020 Mar 17;52(3):542-556.e13. doi: 10.1016/j.immuni.2020.02.007.
   
   
2. Kawaguchi T, Yoshio S, Sakamoto Y, Hashida R, Koya S, Hirota K, Nakano D, Yamamura S, Niizeki T, Matsuse H, Torimura T.
   Impact of Decorin on the Physical Function and Prognosis of Patients with Hepatocellular Carcinoma. J Clin Med. 2020 Mar 28;9(4):936. doi: 10.3390/jcm9040936.
   
   
3. Komatsu H, Inui A, Yoshio S, Fujisawa T.
   Pharmacotherapy options for managing hepatitis B in children. Expert Opin Pharmacother. 2020 Oct 22. doi: 10.1080/14656566.2020.1841165. Online ahead of print.